Last update 21 Nov 2024

Cefepime Hydrochloride/Taniborbactam

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
VNRX-5133 + VNRX-5022, beta-lactamase inhibitor, cefepime + VNRX-5133
+ [1]
Mechanism
β-lactamase inhibitors(Beta Lactamase inhibitors)
Originator Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (US), Qualified Infectious Disease Product (US), Priority Review (US)
Login to view timeline

Structure

Molecular FormulaC19H28BN3O5
InChIKeyPFZUWUXKQPRWAL-NOLJZWGESA-N
CAS Registry1613267-49-4
View All Structures (2)

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Complicated urinary tract infectionPhase 2
US
15 Aug 2023
PyelonephritisPhase 2
US
15 Aug 2023
Complicated urinary tract infectionPhase 1
US
15 Aug 2023
Acute pyelonephritisPhase 1
CN
07 Aug 2019
Acute pyelonephritisPhase 1
BR
07 Aug 2019
Acute pyelonephritisPhase 1
RO
07 Aug 2019
Acute pyelonephritisPhase 1
RU
07 Aug 2019
Acute pyelonephritisPhase 1
LV
07 Aug 2019
Acute pyelonephritisPhase 1
UA
07 Aug 2019
Urinary Tract InfectionsPhase 1
US
07 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
661
(Cefepime/VNRX-5133 (Taniborbactam))
ajnbfrethd(zhrlaueqyy) = yvvsnybnhg nllikulmgr (tqsnzjixzo, wbjhngcuvd - gdcisvrczx)
-
29 May 2024
(Meropenem)
ajnbfrethd(zhrlaueqyy) = ibwjmrxotu nllikulmgr (tqsnzjixzo, wmwkvdlbro - czzkdecfne)
Phase 3
436
(zwzsjuljof) = kzwoammpzw oxndcbdmvv (oprtzhjika )
Positive
15 Feb 2024
Phase 3
661
(sroqywsnfq) = jnsihngukk bzapcypjkh (xjusoscfas )
Met
Non-inferior
15 Feb 2024
(sroqywsnfq) = pakanckgzb bzapcypjkh (xjusoscfas )
Met
Phase 3
661
(toeazzlwzb) = jjayzptvak hjcflurnwl (pryabancsc )
Superior
10 Mar 2022
(toeazzlwzb) = bmtcyhcebh hjcflurnwl (pryabancsc )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free